Galactosamine
- Name
- Galactosamine
- Accession Number
- DBCAT005629
- Description
Not Available
- Drugs
Drug Drug Description Fitusiran Fitusiran is under investigation in clinical trial NCT02554773 (An Open-label Extension Study of an Investigational Drug, ALN-AT3SC, in Patients With Moderate or Severe Hemophilia A or B). Givosiran A 5-aminolevulinic acid synthase-directed small interfering RNA (siRNA) used in the prophylaxis of acute hepatic porphyria. - Drugs & Drug Targets
Drug Target Type Givosiran ALAS1 mRNA target